secwatch.observer — SEC 8-K summary
======================================

Issuer:     VYNE Therapeutics Inc. (VYNE)
CIK:        0001566044
Form:       8-K
Filed at:   2025-09-12T23:59:59+00:00
Accession:  0001104659-25-089531
Event type: regulatory
Sentiment:  negative
Materiality: 0.85
Item codes: 3.01
LLM model:  deepseek-v4-flash:cloud@v2

VYNE receives Nasdaq bid price deficiency notice; 180-day cure period to March 2026
--------------------------------------------------------------------------------

- Closing bid price of VYNE common stock below $1.00 for 30 consecutive business days.
- 180-day compliance period until March 10, 2026; stock continues trading on Nasdaq Capital Market.
- Compliance regained if bid price closes at $1.00+ for 10 consecutive trading days before deadline.
- Company evaluating options; may seek second 180-day period if not compliant by March 10, 2026.
- Failure to regain compliance could result in delisting of common stock.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1566044/000110465925089531/0001104659-25-089531-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1566044/000110465925089531/tm2525917d1_8k.htm
  HTML page:      https://secwatch.observer/filing/0001104659-25-089531

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer